Proprietary implant-to-implant (i2i) device technology is used for communication between two implanted leadless pacemakers to regulate the heart rate
It has signed an MoU with Plan India to expand its reach to Karnataka
The immunogens being tested in IAVI G002 were developed by scientific teams at IAVI and Scripps Research and will be delivered via Moderna's mRNA technology
CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
New role strengthens Quantori’s global leadership position in data science & digital IT
The collaboration with Sanofi signifies a considerable investment in the UK’s Life Sciences sector and, along with other future strategic partners, has the potential to increase the pipeline of potential treatment options for a wide range of common and other life-threatening diseases
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
First launches expected in H1 2022
Ram’s appointment follows the launch of the CDI India division in October 2021.
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
Subscribe To Our Newsletter & Stay Updated
